Yungjin Pharm. Co., Ltd. (003520.KS) KSC

Currency In KRW

AD

Valuation

Market Cap389.03B
Enterprise Value454.6B
P/E Ratio-62.66
PEG Ratio-0
Price/Sales Ratio0.84
Price/Book Ratio2.39
Enterprise/Revenue1.15
Enterprise/EBITDA38.9

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin-0
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.04

Income Statement

Revenue254.26B
Revenue/Share1,388.47
Gross Profit75.86B
EBITDA12.2B
Net Income-227.66M
Diluted EPS-1.24

Balance Sheet

Total Cash6.27B
Total Cash/Share34.26
Total Debt85.15B
Total Debt/Equity0.96
Current Ratio1.66
Book Value Per Share485.57

Price History

52-Week Change-50.38
52-Week High2,385
52-Week Low1,154
Moving Average 50 Days1,534.92
Moving Average 200 Days1,841.24

Statistics

Average Volume369,623
Shares Outstanding182.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor563:500
Last Split DateJune 18, 2010
AD